Florence, January 17, 2024
Ikonisys SA, a company specializing in the early and accurate diagnosis of cancer through a unique and fully automated solution for medical testing laboratories, is pleased to announce the installation of the Ikoniscope at Hospitex Lab. Hospitex Lab is the pathology anatomy laboratory located at the Hospitex International headquarters.
This integration provides an ideal platform for the business operations of Ikonisys Europe, which will use the laboratory as a showroom, demonstration point, training center and center of excellence for FISH technology.
To this end, a series of promotional initiatives are planned with the participation of leading representatives of the medical and scientific community, first in Italy and then at the European level.
Ikonoscope’s FISH technology will also be used internally by integrating it into Urine24, Hospitex’s consumer oncology diagnostic product, further improving its sensitivity, reliability and efficiency.
Finally, an offer to provide FISH technology as-a-service is being studied, targeting small private and public centers that do not have sufficient staff to handle a full installation, thus representing an additional source of revenue for the Group in the medium term.
Mario Crovetto, CEO of Ikonisys, and Francesco Trisolini, CEO of Hospitex International, comment:
“Early developments indicate that the integration of the two companies, which announced their merger plans in early December, is progressing at a record pace. These developments also underscore the significance of this transaction, as it aims to create substantial operational and business synergies.”
